We are live on ! Find out more
LAB icon

Standard BioTools
LAB

98 hedge funds and large institutions have $182M invested in Standard BioTools in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 21

1% more funds holding

Funds holding: 97 → 98 (+1)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

26% less capital invested

Capital invested by funds: $246M → $182M (-$63.8M)

64% less call options, than puts

Call options by funds: $126K | Put options by funds: $349K

Holders
98
Holders Change
+1
Holders Change %
+1.03%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
34
Reduced
21
Closed
13
Calls
$126K
Puts
$349K
Net Calls
-$223K
Net Calls Change
-$204K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$7.25M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.51M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$3.03M
4
EA
Emerald Acquisition
Washington
+$2.36M
5
EAM
EverPoint Asset Management
Connecticut
+$2.11M

Top Sellers

1
CWAM
Columbia Wanger Asset Management
Illinois
-$16M
2
ECM
Endurant Capital Management
California
-$2.32M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.83M
4
GTC
Ghost Tree Capital
New York
-$1.35M
5
PC
Polar Capital
United Kingdom
-$489K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWMPD
76
Integrated Wealth Management (Palm Desert)
California
$17K – – –
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$16.1K +$8.12K +884 +78%
Canada Life
78
Canada Life
Manitoba, Canada
$14K – – –
Bank of America
79
Bank of America
North Carolina
$11K -$9.02K -982 -41%
PNC Financial Services Group
80
PNC Financial Services Group
Pennsylvania
$9K -$1.69K -184 -14%
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$8K – – –
QCG
82
Quadrant Capital Group
Ohio
$8K – – –
MFW
83
Mosaic Family Wealth
Missouri
$6K – – –
SIM
84
Sonora Investment Management
Arizona
$4K – – –
Fifth Third Bancorp
85
Fifth Third Bancorp
Ohio
$4K +$4.74K +516 New
Federated Hermes
86
Federated Hermes
Pennsylvania
$3K – – –
Zurich Cantonal Bank
87
Zurich Cantonal Bank
Switzerland
$3K – – –
PIA
88
Piedmont Investment Advisors
North Carolina
$1.49K +$1.71K +186 New
TRCT
89
Tower Research Capital (TRC)
New York
$1K -$9.7K -1,056 -89%
AG
90
Advisor Group
Arizona
$1K – – –
QI
91
QS Investors
New York
$1K +$110 +12 +41%
CSS
92
Cubist Systematic Strategies
Connecticut
$1K +$1.13K +123 New
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$1K +$1.28K +139 New
TCIM
94
TIAA CREF Investment Management
New York
$844 +$77.3K +8,418 +9%
VOYA Investment Management
95
VOYA Investment Management
Georgia
$127 – – –
CWAM
96
Columbia Wanger Asset Management
Illinois
– -$16M -1,777,282 Closed
ECM
97
Endurant Capital Management
California
– -$2.32M -256,490 Closed
GTC
98
Ghost Tree Capital
New York
– -$1.35M -150,000 Closed
PC
99
Polar Capital
United Kingdom
– -$489K -54,132 Closed
IHM
100
Iguana Healthcare Management
New York
– -$452K -50,000 Closed
1 2 3
4
5

LAB Hedge Fund Activity: Q3 2016 in Review

98 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2016, worth a combined $182M — down 26% from $246M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LAB positions and 13 closed out — a net gain of 1 holder — while 34 added to existing stakes and 21 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $7.25M. The largest seller was Columbia Wanger Asset Management, exiting entirely with an estimated $16M sold.

  • 98 institutional investors held Standard BioTools (LAB) as of Q3 2016, up from 97 in Q2 2016.
  • Funds reported $182M of Standard BioTools stock for Q3 2016, down 26% quarter-over-quarter.
  • 14 funds opened new Standard BioTools positions in Q3 2016 and 13 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q3 2016 was Levin Capital Strategies, an estimated $7.25M added.
  • The largest Standard BioTools seller in Q3 2016 was Columbia Wanger Asset Management, an estimated $16M sold.

Based on aggregated 13F filings for Q3 2016.